Not applicableUnknownNCT05550766What this trial is testingPrognostic Value of RXR-α in Cutaneous Squamous and Basal Cell CarcinomaWho this might be right forNon-melanoma Skin Cancer Sohag University 50
Early research (Phase 1)Active Not RecruitingNCT03929029What this trial is testingNeoantigen Vaccine Plus Locally Administered Ipilimumab and Systemic Nivolumab in Advanced MelanomaWho this might be right forCutaneous Melanoma Dana-Farber Cancer Institute 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT04645680What this trial is testingDiet and Immune Effects Trial: DIET- A Randomized Double Blinded Dietary Intervention Study in Patients With Metastatic Melanoma Receiving ImmunotherapyWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Melanoma+7 more M.D. Anderson Cancer Center 50
Large-scale testing (Phase 3)UnknownNCT01502696What this trial is testingAdjuvant PEG Intron in Ulcerated MelanomaWho this might be right forUlcerated Melanomas European Organisation for Research and Treatment of Cancer - EORTC 1,200
Testing effectiveness (Phase 2)Ended earlyNCT05219578What this trial is testingRTX-224 Monotherapy in Patients With Solid TumorsWho this might be right forNon Small Cell Lung CancerCutaneous MelanomaHead and Neck Squamous Cell Carcinoma+2 more Rubius Therapeutics 7
Early research (Phase 1)Active Not RecruitingNCT05176470What this trial is testingNeoadj Admin Autologous Tumor Infiltrating Lymphocytes & Pembrolizumab for Treatment of Adv Melanoma PatientsWho this might be right forLocally Advanced MelanomaPathologic Stage IIIB Cutaneous Melanoma AJCC v8Pathologic Stage IIIC Cutaneous Melanoma AJCC v8+2 more Richard Wu 2
Not applicableStudy completedNCT05079113What this trial is testingLeveraging ctDNA Analysis to Improve Early Detection of Cancer Recurrence in the High-Risk Melanoma SettingWho this might be right forStage III MelanomaStage IV Cutaneous Melanoma Case Comprehensive Cancer Center 73
Early research (Phase 1)Study completedNCT01017185What this trial is testingStudy of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial LesionsWho this might be right forRefractory Head and Neck CancerSquamous Cell Carcinoma, SkinCarcinoma of the Breast+1 more Takara Bio Inc. 28
Very early researchLooking for participantsNCT06305962What this trial is testing177Lu-anti-PD-L1 sdAb in Metastatic Solid TumorsWho this might be right forPDL1 Gene MutationNon Small Cell Lung CancerSmall Cell Lung Cancer ( SCLC )+6 more Radiopharm Theranostics, Ltd 30
Not applicableStudy completedNCT04365244What this trial is testingPruritus and Melanoma and Cutaneous Carcinomas Treated With ImmunotherapyWho this might be right forPruritus University Hospital, Brest 181
Not applicableStudy completedNCT05172232What this trial is testingDiagnostic Precision of the AI Tool Dermalyzer to Identify Malignant Melanomas in Subjects Seeking Primary Care for Melanoma-suspected Cutaneous LesionsWho this might be right forMalignant Melanoma Linkoeping University 231
Early research (Phase 1)Study completedNCT03458117What this trial is testingT-VEC in Non-melanoma Skin CancerWho this might be right forNon-melanoma Skin CancerBasal Cell CarcinomaSquamous Cell Carcinoma+2 more University of Zurich 26
Early research (Phase 1)Active Not RecruitingNCT03769155What this trial is testingVX15/2503 With or Without Ipilimumab and/or Nivolumab in Patients With Resectable Stage IIIB-D MelanomaWho this might be right forPathologic Stage IIIB Cutaneous Melanoma AJCC v8Pathologic Stage IIIC Cutaneous Melanoma AJCC v8Pathologic Stage IIID Cutaneous Melanoma AJCC v8 Emory University 41
Early research (Phase 1)Looking for participantsNCT04855435What this trial is testingSafety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid TumoursWho this might be right forAdvanced Solid TumorUveal Melanoma, MetastaticCutaneous Melanoma MonTa Biosciences ApS 106
Large-scale testing (Phase 3)UnknownNCT00005052What this trial is testingVaccine Therapy in Treating Patients With Primary Stage II MelanomaWho this might be right forMelanoma (Skin) European Organisation for Research and Treatment of Cancer - EORTC
Testing effectiveness (Phase 2)Looking for participantsNCT05267626What this trial is testingStudy of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic CancerWho this might be right forAdvanced Solid TumorMetastatic CancerCutaneous Melanoma+1 more Aulos Bioscience, Inc. 159
Testing effectiveness (Phase 2)Study completedNCT03033576What this trial is testingTesting Treatment With Ipilimumab and Nivolumab Compared to Treatment With Ipilimumab Alone in Advanced MelanomaWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Melanoma of Unknown Primary+3 more National Cancer Institute (NCI) 94
Testing effectiveness (Phase 2)Study completedNCT03541148What this trial is testingEvaluation of Oncoxin-Viusid® in Cutaneous MelanomaWho this might be right forCutaneous Melanoma, Stage IIMalignant Cutaneous MelanomaCutaneous Melanoma, Stage III Catalysis SL 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07807878What this trial is testingTrial of Temozolomide in BAP1 Mutated Patients With Advanced or Metastatic Cutaneous MelanomaWho this might be right forCutaneous Melanoma Assistance Publique Hopitaux De Marseille 28
Early research (Phase 1)Study completedNCT02110355What this trial is testingA Phase 1b/2a Study Evaluating AMG 232 in Metastatic MelanomaWho this might be right forAdvanced MalignancyAdvanced Solid TumorsCancer+4 more Kartos Therapeutics, Inc. 31